9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares
39,677,394,773
Series A Preferred Shares
8,341,500
Series B Preferred Shares
16,658,500
11. Indicate the item numbers reported herein
Item 9 - Other Events
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
ACEN CORPORATIONACEN
PSE Disclosure Form 16-1- Update on Corporate Actions/ Material Transactions/Agreements References: SRC Rule 17 (SEC Form 17-C) and Section 16 of the Revised Disclosure Rules
Subject of the Disclosure
Update on the Joint Venture of ib vogt (Singapore) Pte. Ltd. and ACEN Renewables International Pte. Ltd.
Background/Description of the Disclosure
By way of update to the 24 October 2024 disclosure on the joint venture company, IBV ACEN Renewables Asia Pte. Ltd. (the "JV Company"), the JV Company is currently in the final stages of assessing and finalizing an investment in various solar PV project opportunities in Malaysia (c.80MW in aggregate).
This c.USD13 million investment is part of ACEN's expected contribution of up to USD200 million equity investment as the JV Company targets a minimum operational capacity of 1,000 MW across Asia Pacific with potential for future expansion.
DISCLAIMER: This disclosure may contain forward-looking statements that are subject to risk factors and opportunities that may affect ACEN’s plans to complete the transaction/s subject of this disclosure. Each forward-looking statement is made only as of the date of this disclosure. Outcomes of the subject transaction may differ materially from those expressed in the forward-looking statements included in this disclosure.
Other Relevant Information
This disclosure is related to Disclosure Report Nos. C06760-2024 dated 24 October 2024, and C06513-2023 dated 18 August 2023, which was posted on 22 August 2023.
Filed on behalf by:
Name
Dodjie Lagazo
Designation
General Counsel; Assistant Corporate Secretary; Compliance Officer